Shiladitya Sengupta

Brigham and Women's Hospital — United States

Materials Science · Physical Sciences

39h-index6.2kcitations168works19.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Nanoparticle-Based Drug Delivery(39), Nanoplatforms for cancer theranostics(32), Immunotherapy and Immune Responses(14), RNA Interference and Gene Delivery(14), Cancer Cells and Metastasis(13)

Publications167 total

Topical mycophenolate for the treatment of uveitis-associated inflammation
Journal of Ophthalmic Inflammation and Infection·2026Open Access
A strategically designed homogeneous antibody-drug conjugate improves safety and therapeutic index in renal cell carcinoma
2026
Topical mycophenolate for the treatment of uveitis-associated inflammation
Figshare·2026Open Access
Topical mycophenolate for the treatment of uveitis-associated inflammation
Figshare·2026Open Access
Additional file 1 of Topical mycophenolate for the treatment of uveitis-associated inflammation
Figshare·2026Open Access
Additional file 1 of Topical mycophenolate for the treatment of uveitis-associated inflammation
Figshare·2026Open Access
Abstract CT091: Interim results from a phase 2 trial testing the safety and efficacy of VT-1953 topical gel in patients with malodorous malignant fungating wound
Cancer Research·2025
Abstract 4300: AT1965, a novel mRNA cap 2′O methylation inhibitor, exerts potent antitumor activity and enhances chemotherapy efficacy
Cancer Research·2025
Topically Applied VT-1908 Reduces Uveitis-associated Inflammation (Abstract ID: 190259)
Journal of Pharmacology and Experimental Therapeutics·2025
Recommendations for mitochondria transfer and transplantation nomenclature and characterization
Nature Metabolism·2025· 81 citedOpen Access
Intercellular nanotube-mediated mitochondrial transfer enhances T cell metabolic fitness and antitumor efficacy
Cell·2024· 147 citedOpen Access
Antibody nanoparticle conjugate–based targeted immunotherapy for non–small cell lung cancer
Science Advances·2024· 36 citedOpen Access
Abstract 3935: Involvement of nanoscale physical communication in obesity-associated breast cancer severity
Cancer Research·2024
An inexpensive “do-it-yourself” device for rapid generation of uniform tumor spheroids
Device·2024· 2 citedOpen Access
An architecturally rational hemostat for rapid stopping of massive bleeding on anticoagulation therapy
Proceedings of the National Academy of Sciences·2024· 22 citedOpen Access
Abstract 5108: Overcoming roadblocks of immunotherapy in non-small cell lung cancer
Cancer Research·2023
Supplementary Figures from Nanoengineered Disruption of Heat Shock Protein 90 Targets Drug-Induced Resistance and Relieves Natural Killer Cell Suppression in Breast Cancer
2023Open Access
Supplementary tables from Nanoengineered Disruption of Heat Shock Protein 90 Targets Drug-Induced Resistance and Relieves Natural Killer Cell Suppression in Breast Cancer
2023Open Access
Supplementary Information from Nanoengineered Disruption of Heat Shock Protein 90 Targets Drug-Induced Resistance and Relieves Natural Killer Cell Suppression in Breast Cancer
2023Open Access
Supplementary Figures from Nanoengineered Disruption of Heat Shock Protein 90 Targets Drug-Induced Resistance and Relieves Natural Killer Cell Suppression in Breast Cancer
2023Open Access
page 1 of 9Next →

Frequent Co-authors

Aaron Goldman(8), Ashish Kulkarni(8), Hae Lin Jang(6), R. A. Mashelkar(6), Shivani Soni(6), Sudipta Basu(6), Rania Harfouche(6), Mohammad Kohandel(5), Abhimanyu S. Paraskar(5), Siva Kumar Natarajan(5), Ram Sasisekharan(4), Tanmoy Saha(4), Pradip K. Majumder(4), Vineethkrishna Chandrasekar(4), Venkata Sabbisetti(4), Biswanath Majumder(3), Padmaparna Chaudhuri(3), Shivani Soni(3), Wujin Sun(3), Peyton Tebon(3)